BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 36593957)

  • 41. The recent progress on metal-organic frameworks for phototherapy.
    Zheng Q; Liu X; Zheng Y; Yeung KWK; Cui Z; Liang Y; Li Z; Zhu S; Wang X; Wu S
    Chem Soc Rev; 2021 Apr; 50(8):5086-5125. PubMed ID: 33634817
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MOF-derived novel porous Fe
    Xiang Z; Qi Y; Lu Y; Hu Z; Wang X; Jia W; Hu J; Ji J; Lu W
    J Mater Chem B; 2020 Sep; 8(37):8671-8683. PubMed ID: 32856668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multifunctional Metal-Organic Framework (MOF)-Based Nanoplatforms for Crop Protection and Growth Promotion.
    Wang CY; Qin JC; Yang YW
    J Agric Food Chem; 2023 Apr; ():. PubMed ID: 37037783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coupling metal organic frameworks with molybdenum disulfide nanoflakes for targeted cancer theranostics.
    Yang S; Li D; Chen L; Zhou X; Fu L; You Y; You Z; Kang L; Li M; He C
    Biomater Sci; 2021 May; 9(9):3306-3318. PubMed ID: 33459315
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Recent advances in metal-organic frameworks and their composites for the phototherapy of skin wounds.
    Yang M; Zhang J; Shi W; Zhang J; Tao C
    J Mater Chem B; 2022 Jun; 10(25):4695-4713. PubMed ID: 35687028
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Noninvasive photothermal cancer therapy nanoplatforms via integrating nanomaterials and functional polymers.
    Ban Q; Bai T; Duan X; Kong J
    Biomater Sci; 2017 Jan; 5(2):190-210. PubMed ID: 27990534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A review of recent developments of metal-organic frameworks as combined biomedical platforms over the past decade.
    Moharramnejad M; Malekshah RE; Ehsani A; Gharanli S; Shahi M; Alvan SA; Salariyeh Z; Azadani MN; Haribabu J; Basmenj ZS; Khaleghian A; Saremi H; Hassani Z; Momeni E
    Adv Colloid Interface Sci; 2023 Jun; 316():102908. PubMed ID: 37148581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Modified nanoscale metal organic framework-based nanoplatforms in photodynamic therapy and further applications.
    Gao D; Gao Y; Shen J; Wang Q
    Photodiagnosis Photodyn Ther; 2020 Dec; 32():102026. PubMed ID: 32979544
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Integration of metal-organic framework with a photoactive porous-organic polymer for interface enhanced phototherapy.
    Zheng X; Wang L; Guan Y; Pei Q; Jiang J; Xie Z
    Biomaterials; 2020 Mar; 235():119792. PubMed ID: 31972286
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metal-organic framework (MOF)-based materials for pyroptosis-mediated cancer therapy.
    Dou Y; Wang Y; Tian S; Song Q; Deng Y; Zhang Z; Chen P; Sun Y
    Chem Commun (Camb); 2024 Jun; 60(51):6476-6487. PubMed ID: 38853690
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Core-shell inorganic NP@MOF nanostructures for targeted drug delivery and multimodal imaging-guided combination tumor treatment.
    Khan S; Falahati M; Cho WC; Vahdani Y; Siddique R; Sharifi M; Jaragh-Alhadad LA; Haghighat S; Zhang X; Ten Hagen TLM; Bai Q
    Adv Colloid Interface Sci; 2023 Nov; 321():103007. PubMed ID: 37812992
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Metal-Organic Frameworks with Enhanced Photodynamic Therapy: Synthesis, Erythrocyte Membrane Camouflage, and Aptamer-Targeted Aggregation.
    Zhao Y; Wang J; Cai X; Ding P; Lv H; Pei R
    ACS Appl Mater Interfaces; 2020 May; 12(21):23697-23706. PubMed ID: 32362109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Tunable metal-organic frameworks assist in catalyzing DNAzymes with amplification platforms for biomedical applications.
    Zhu X; Xu J; Ling G; Zhang P
    Chem Soc Rev; 2023 Oct; 52(21):7549-7578. PubMed ID: 37817667
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal-Clearable Porphyrinic Metal-Organic Framework Nanodots for Enhanced Photodynamic Therapy.
    Wang H; Yu D; Fang J; Cao C; Liu Z; Ren J; Qu X
    ACS Nano; 2019 Aug; 13(8):9206-9217. PubMed ID: 31408319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Recent advances and prospects of metal-organic frameworks in cancer therapies.
    Luo Z; Sheng Y; Jiang C; Pan Y; Wang X; Nezamzadeh-Ejhieh A; Ouyang J; Lu C; Liu J
    Dalton Trans; 2023 Dec; 52(47):17601-17622. PubMed ID: 37953742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antibacterial applications of metal-organic frameworks and their composites.
    Shen M; Forghani F; Kong X; Liu D; Ye X; Chen S; Ding T
    Compr Rev Food Sci Food Saf; 2020 Jul; 19(4):1397-1419. PubMed ID: 33337086
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Supramolecular metal-organic frameworks as host-guest nanoplatforms for versatile and customizable biomedical applications.
    Hu Q; Zhang B; Ren H; Zhou X; He C; Shen Y; Zhou Z; Hu H
    Acta Biomater; 2023 Sep; 168():617-627. PubMed ID: 37482147
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineering Phototheranostic Nanoscale Metal-Organic Frameworks for Multimodal Imaging-Guided Cancer Therapy.
    Cai W; Gao H; Chu C; Wang X; Wang J; Zhang P; Lin G; Li W; Liu G; Chen X
    ACS Appl Mater Interfaces; 2017 Jan; 9(3):2040-2051. PubMed ID: 28032505
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers.
    Wei Q; Wu Y; Liu F; Cao J; Liu J
    J Mater Chem B; 2022 Feb; 10(5):676-699. PubMed ID: 35043825
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent Development of MOF-Based Photothermal Agent for Tumor Ablation.
    Yin X; Ai F; Han L
    Front Chem; 2022; 10():841316. PubMed ID: 35372266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.